Randomised Clinical Trials and Observational Studies: the Ratio in the Hierarchy of Evidence of the Efficacy of Drugs
Authors:
- S. Yu. MartsevichSMS. Yu. Martsevich
- N. P. KutishenkoNKN. P. Kutishenko
Open Access
- 1 January 2016
- journal article
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 12 (5) , 567-573
Abstract
The role of randomized controlled trials (RCTs) and observational studies in evaluation of the efficacy and safety of cardiology drugs is compared in the article. The clear conclusion is made that RCTs are the basis of modern evidence-based medicine, and that they have no alternative. Observational studies conducted in compliance with the modern rules can be a source of information on the efficacy of drugs only in the absence of data from RCTs.Keywords
This publication has 16 references indexed in Scilit:
- Drug-Eluting or Bare-Metal Stents for Coronary Artery DiseaseNew England Journal of Medicine, 2016
- β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery DiseaseJAMA, 2012
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine, 2011
- De testimonio: on the evidence for decisions about the use of therapeutic interventionsThe Lancet, 2008
- Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confoundingBMJ, 2005
- Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studiesThe Lancet, 2001
- Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trialsThe Lancet, 2001
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- Observational studies of drug safetyThe Lancet, 1996
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991